Login

Switch On Your HIV Smarts.

Antibody therapies effective at preventing HIV from invading CD4 cells

Antibody therapies effective at preventing HIV from invading CD4 cells

, by Liz Highleyman

Research on two new long-acting antibody therapies demonstrates success at protecting CD4 cells and suppressing viral loads in people living with HIV. Read More

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

, by Liz Highleyman

Two new HIV drugs, an NNRTI and an integrase inhibitor, did well in clinical trials and are currently being tested as part of fixed-dose co-formulated pills. Read More

Simpler HIV treatment, with only 2 drugs, keeps viral loads suppressed

Simpler HIV treatment, with only 2 drugs, keeps viral loads suppressed

, by Liz Highleyman

People taking only two drugs, dolutegravir and rilpivirine, maintained viral suppression in participants of the SWORD-1 an SWORD-2 studies. Read More

Sci-fi ways to treat HIV: Implants, monoclonal antibodies & more

Sci-fi ways to treat HIV: Implants, monoclonal antibodies & more

, by Emily Land

Researchers are working on new treatment options that will make treating HIV easier than ever before. Read More

New research shows abnormal immune activation even in very early HIV infection

New research shows abnormal immune activation even in very early HIV infection

, by Emily Land

Findings may help explain why early ART may improve, but fail to fully restore, health and life expectancies of people living with HIV on therapy. Read More